Clinical Cardiology Alert – September 1, 2012
September 1, 2012
View Issues
-
Angiotensin-Converting Enzyme Inhibitor Use in Coronary Artery Bypass Graft Surgery
Angiotensin-converting enzyme inhibitor (ACEI) therapy may be beneficial during coronary artery bypass graft (CABG) surgery because of its anti-inflammatory and other vascular benefits. -
Estimating Stroke and Bleeding Risk in Atrial Fibrillation
Various risk schemes have been promulgated for assessing the risk of stroke and bleeding in patients with atrial fibrillation (AF). These investigators used the Swedish Atrial Fibrillation cohort study to investigate the comparative utility of four schemes that have been validated in AF cohorts: CHADS2, CHA2DS2-VASc, HAS-BLED, and HEMORR2HAGES. -
Anticoagulant Strategy for Device Implantation
In this paper, the authors perform a systematic review and meta-analysis of published reports comparing anticoagulation management strategies around the time of cardiac rhythm device implantation. Using standard techniques, the authors searched the medical literature and identified studies that assessed two or more anticoagulation strategies around the time of cardiac rhythm device implantation. -
Radial vs Femoral Access in STEMI
Primary percutaneous coronary intervention (PCI) saves lives in patients suffering from ST-elevation myocardial infarction (STEMI). -
A Better Technique for Ablation of Persistent Atrial Fibrillation?
This paper discusses the clinical utility of impulse and rotor mapping to guide atrial fibrillation (AF) ablation and is a follow-up to the acute observations discussed in Clinical Cardiology Alert several months ago.1 The authors hypothesized that AF is sustained by localized sources that may be targeted during AF ablation procedures. -
Pharmacology Watch: Does Finasteride Cause Permanent Sexual Side Effects?
Side effects of finasteride; new ruling on pharmaceutical companies paying generic manufacturers; and FDA actions. -
Clinical Briefs in Primary Care Supplement